9[5]Jaillon P,Morganroth J,Brumpt I,et al.Overview of electrocardiographic and cardiovascular safety data for sparfloxacin.Sparfloxacin Safety Group [J].J Antimicrob Chemother,1996,37( Suppl A ): 161.
10[6]Ball P,Mandell L,Patou G,et al.A new respiratory fluoroquinolone,oral gemifloxacin:a safety profile in context[J].Int J Antimicrob Agents,2004,23 ( 5 ) :421.